| Autor: |
Grover, Kavita M., Sripathi, Naganand |
| Předmět: |
|
| Zdroj: |
Seminars in Neurology; Oct2022, Vol. 42 Issue 5, p594-610, 17p |
| Abstrakt: |
In this article, we review prevention of serious adverse clinical outcomes and treatment side effects in patients with neuromuscular disorders including myopathies and myasthenia gravis. While neither of these entities is preventable, their course can often be modified, and severe sequelae may be prevented, with the identification of risk factors and proactive attention toward treatment planning. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
